back pain~|~cardiac arrhythmia~|~phosphorus~|~constipation~|~satisfaction~|~xerostomia~|~dietary phosphorus~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~adverse event associated with cardiac arrhythmia~|~constipation, ctcae~|~emotionally satisfied with extremity~|~fighting~|~have constipation~|~how much distress constipation~|~how often constipation~|~nr4a2 gene~|~negation~|~not otherwise specified~|~phosphate measurement~|~phosphorus drug class~|~satisfied~|~usual severity constipation~|~dry mouth, ctcae~|~have dry mouth~|~how much distress dry mouth~|~how often dry mouth~|~usual severity dry mouth
hot temperature~|~pain~|~chest pain~|~dyspnea~|~nausea~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal~|~adhfe1 gene~|~bothered by nausea~|~feel nausea~|~have~|~have nausea~|~have shortness of breath question~|~hot sensation quality~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity nausea~|~usual severity shortness of breath~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
menthol~|~hematuria~|~satisfaction~|~candy~|~communicable diseases~|~zetia~|~emotionally satisfied with extremity~|~nr4a2 gene~|~negation~|~satisfied~|~ehd1 wt allele~|~hematuria, ctcae~|~in the past~|~infectious disease pathway~|~mental status change~|~menthol flavor~|~not otherwise specified~|~specific qualifier value~|~status~|~what subject filter - status~|~candy dosage form
nausea~|~satisfaction~|~bothered by nausea~|~emotionally satisfied with extremity~|~entire bone (organ)~|~entire bony skeleton~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~satisfied~|~skeletal bone~|~specific qualifier value~|~specimen source codes - bone~|~specimen type - bone~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~usual severity nausea~|~acute pain due to trauma~|~generalized aches and pains
urinary tract infection~|~satisfaction~|~generalized abdominal pain~|~emotionally satisfied with extremity~|~infection by site~|~nr4a2 gene~|~negation~|~not otherwise specified~|~recurrent urinary tract infection~|~satisfied~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~urinary tract infection, ctcae~|~abdominal tenderness~|~generalized aches and pains~|~urinary pain
hospice care~|~cardiac arrhythmia~|~heart atrium~|~unspecified~|~neck injuries~|~adverse event associated with cardiac arrhythmia~|~fbl gene~|~relations~|~relative (related person)~|~hospice environment
s-adenosylmethionine~|~hallucinations~|~andorra~|~epileptic syndromes~|~epilepsy~|~foot~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~best1 gene~|~emotional well-being~|~emotional state observations~|~emotional states~|~father (person)~|~father - courtesy title~|~feet, unit of measurement~|~fighting~|~generalized~|~hallucinations, ctcae~|~in addition to~|~indirect exposure mechanism - father~|~involvement with~|~medial~|~relationship - father~|~same~|~specific qualifier value~|~with - dosing instruction fragment~|~best (quality)~|~same - roleclassontological~|~size
hospice care~|~world health organization~|~andorra~|~best1 gene~|~fighting~|~nr4a2 gene~|~negation~|~best (quality)~|~and~|~and - dosing instruction fragment~|~biological factors~|~drugs - dental services~|~indeterminate~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~pharmaceutical preparations~|~physical aggression~|~relationshipconjunction - and~|~surface acoustic wave device~|~thinking, function~|~undetermined~|~undetermined finding~|~who temperature/humidity storage condition~|~analogy~|~hospice environment~|~saw (device)
opioid-related disorders~|~mental recall~|~adult~|~disease
leg~|~lower extremity~|~entire lower leg, from knee to ankle~|~entire lower limb~|~fused~|~have~|~injury of prostate~|~ipss risk category low~|~ipss-r risk category low~|~low - messagewaitingpriority~|~low - observation~|~low level~|~low mitosis-karyorrhexis index~|~value below reference range~|~low~|~low confidentiality~|~low exposure
sepsis~|~septicemia~|~disease~|~membrane~|~false~|~membrane device~|~organism~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~tissue membrane~|~without~|~regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway
hot temperature~|~helium~|~dizziness~|~hac protocol~|~lightheadedness~|~major depressive disorder~|~nausea~|~unipolar depression~|~alcohol consumption~|~nr4a2 gene~|~negation~|~adhfe1 gene~|~best1 gene~|~bothered by nausea~|~emotional well-being~|~emotional state observations~|~emotional states~|~feel nausea~|~feeling suicidal (finding)~|~fighting~|~hadh gene~|~have~|~have nausea~|~hot sensation quality~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in addition to~|~involvement with~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~specific qualifier value~|~usual severity nausea~|~with - dosing instruction fragment~|~best (quality)~|~seen~|~aspects of signs~|~cytip gene~|~manufactured sign~|~physical findings
nausea~|~symptoms~|~andorra~|~and~|~and - dosing instruction fragment~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~relationshipconjunction - and~|~symptoms aspect~|~toxic effect of carbon monoxide~|~usual severity nausea
asbestos~|~nausea~|~vomiting~|~maintenance~|~bothered by nausea~|~feel nausea~|~fighting~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in addition to~|~maintenance clinical trial setting~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~powder dosage form category~|~powder dose form~|~specific qualifier value~|~usual severity nausea~|~with - dosing instruction fragment~|~diabetic~|~powder physical state~|~bothered by vomiting~|~chronic - admission level of care code~|~chronic debility~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~provision of recurring care for chronic illness~|~usual severity vomiting~|~vomiting, ctcae~|~chronic
hospice care~|~human body~|~craniocerebral trauma~|~satisfaction~|~ankle injuries~|~patient in hospital~|~adult human body~|~best1 gene~|~body of stomach~|~body structure~|~document body~|~emotionally satisfied with extremity~|~entire thigh~|~human body structure~|~injury of lower leg~|~quantity~|~satisfied~|~thigh structure~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~whole body~|~best (quality)~|~hospice environment~|~trauma to the abdomen
pap smear~|~papanicolaou test~|~not otherwise specified
cardiac arrest~|~betaseron~|~satisfaction~|~cardiac arrest, ctcae 5~|~cdisc sdtm adverse event outcome terminology~|~emotionally satisfied with extremity~|~out (direction)~|~removed~|~result~|~satisfied~|~specific qualifier value~|~tcf23 gene
hospice care~|~andorra~|~craniocerebral trauma~|~eye~|~transplantation~|~patient in hospital~|~ankle injuries~|~foot injuries~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~transplant~|~entire eye~|~eye specimen~|~eye specimen source code~|~injury of lower leg~|~orbital region~|~order (action)~|~order (arrangement)~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hospice environment~|~angular~|~transplanted tissue
apnea~|~classification~|~disease~|~mental recall~|~ask protein, human~|~negative surgical margin~|~adult~|~fatigue~|~nr4a2 gene~|~negation~|~membrane~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~apnea, ctcae~|~best1 gene~|~clear~|~dbf4 gene~|~dbf4 wt allele~|~epidermal cgvhd score 0~|~fighting~|~high~|~membrane device~|~not otherwise specified~|~patient in hospital~|~remote control command - clear~|~tissue membrane~|~best (quality)~|~doubt~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue~|~legal adult
pain~|~throat~|~hyperglycemia~|~satisfaction~|~breast~|~anterior portion of neck~|~emotionally satisfied with extremity~|~entire breast~|~entire throat (surface region of neck)~|~father (person)~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~in addition to~|~nr4a2 gene~|~negation~|~pharyngeal structure~|~satisfied~|~specific qualifier value~|~specimen source codes - throat~|~specimen type - throat~|~throat homeopathic medication~|~with - dosing instruction fragment~|~diabetic~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~generalized aches and pains~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
cerebral hemorrhage~|~unconscious state~|~hemorrhoids~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~not otherwise specified~|~patient visit~|~visit~|~early complication of trauma~|~external cause codes: unspecified~|~female genital injuries~|~hemorrhoids, ctcae 3.0~|~hemorrhoids, ctcae 5.0~|~male genital injuries~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~pending - allergy clinical status~|~pending - day type~|~pending - referral status~|~pending - status~|~resolution~|~resolved~|~resolved license~|~specific qualifier value~|~traumatic~|~traumatic injury~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~counts~|~pending - managedparticipationstatus~|~pending - rolestatus~|~physiologic resolution~|~trauma qualifier~|~urologic injuries~|~cerebral hemisphere hemorrhage~|~code system type - internal~|~internal~|~non mouse~|~negation
pain~|~spasm~|~nausea~|~vomiting~|~alcohol dependence with withdrawal, unspecified~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~alcohol withdrawal syndrome~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~myotonus (finding)~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~specific qualifier value~|~usual severity nausea~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
pain~|~not otherwise specified~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
seizures~|~nausea~|~alcohol consumption~|~disease~|~membrane~|~bothered by nausea~|~father (person)~|~father - courtesy title~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~indirect exposure mechanism - father~|~membrane device~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~relationship - father~|~specific qualifier value~|~tissue membrane~|~usual severity nausea~|~doubt
diabetes mellitus~|~hypercholesterolemia~|~headache~|~hyperglycemia~|~meningitis~|~generalized abdominal pain~|~diabetes~|~father (person)~|~father - courtesy title~|~fighting~|~glucose in blood specimen above reference range~|~headache, ctcae~|~hypercholesterolemia result~|~hyperglycemia, ctcae~|~in addition to~|~indirect exposure mechanism - father~|~meningitis, ctcae~|~relationship - father~|~with - dosing instruction fragment~|~spells (neurological symptom)~|~generalized aches and pains~|~unspecified
alcohol consumption~|~specific qualifier value
pain~|~hospice care~|~ankle~|~forearm~|~satisfaction~|~forearm injuries~|~specific qualifier value~|~ankle joint structure~|~emotionally satisfied with extremity~|~entire ankle region~|~entire lower lip~|~lower lip structure~|~nr4a2 gene~|~negation~|~patient in hospital~|~satisfied~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hospice environment~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain in forearm~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
asthma~|~back pain~|~satisfaction~|~united arab emirates~|~constipation~|~wheezing~|~emotionally satisfied with extremity~|~nr4a2 gene~|~negation~|~satisfied~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~androgen response element~|~asthma pathway~|~in addition to~|~with - dosing instruction fragment~|~are unit of measure~|~exacerbation acute~|~general symptom~|~wheezing, ctcae
asbestos~|~mental orientation~|~satisfaction~|~brain~|~italy~|~cdisc adas-cog - orientation summary score~|~cerebral hemisphere structure (body structure)~|~emotionally satisfied with extremity~|~fighting~|~genomic orientation~|~montreal cognitive assessment orientation test~|~nr4a2 gene~|~negation~|~orientation (spatial)~|~satisfied~|~specific qualifier value~|~feeling tense~|~intrathecal route of drug administration~|~tension
vision~|~urinary tract infection~|~nose~|~mental orientation~|~nose diseases~|~satisfaction~|~recurrent urinary tract infection~|~urinary tract infection, ctcae~|~cdisc adas-cog - orientation summary score~|~emotionally satisfied with extremity~|~entire nose~|~external cause codes: unspecified~|~genomic orientation~|~have~|~infection by site~|~mental status change~|~montreal cognitive assessment orientation test~|~nr4a2 gene~|~negation~|~not otherwise specified~|~orientation (spatial)~|~satisfied~|~side~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~west (direction)~|~fever with chills
patients~|~disabled person code - patient~|~mail claim party - patient~|~mental status change~|~nr4a2 gene~|~negation~|~not otherwise specified~|~relationship modifier - patient~|~report source - patient~|~specimen source codes - patient~|~specimen type - patient~|~veterinary patient~|~nausea and vomiting
abdominal pain~|~constipation~|~intestinal obstruction~|~satisfaction~|~zetia~|~in addition to~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized aches and pains~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~constipation, ctcae~|~emotionally satisfied with extremity~|~epidermal cgvhd score 4~|~grade 3 severe adverse event~|~have constipation~|~how much distress constipation~|~how often constipation~|~intensity and distress 5~|~nr4a2 gene~|~negation~|~satisfied~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~usual severity constipation
cardiac arrhythmia~|~satisfaction~|~adverse event associated with cardiac arrhythmia~|~breath~|~ehd1 wt allele~|~emotionally satisfied with extremity~|~in the past~|~nr4a2 gene~|~negation~|~precision - year~|~satisfied~|~shortened~|~transaction counts and value totals - year~|~year~|~chronic debility~|~unspecified
emend~|~current (present time)~|~electrical current~|~have~|~not otherwise specified~|~status~|~what subject filter - status
pain~|~health status~|~chest pain~|~chest~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~relationship - father~|~specific qualifier value~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~anterior thoracic region~|~cdisc send laboratory animal species terminology~|~entire limb~|~limb structure~|~send test system common name~|~species~|~species - nature of abnormal testing~|~chest pain:finding:point in time:^patient:ordinal
andorra~|~precision - year~|~transaction counts and value totals - year~|~year~|~and~|~and - dosing instruction fragment~|~aspects of mortality statistics~|~definable~|~definition~|~known~|~mortality vital statistics~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~relationshipconjunction - and~|~sufficiently defined concept definition status (core metadata concept)~|~etiology aspects~|~science of etiology
hallucinations~|~nurse administrator~|~hallucinations, auditory~|~diazooxonorleucine~|~chantix~|~satisfaction~|~theses~|~volition~|~emotionally satisfied with extremity~|~external cause codes: unspecified~|~hallucinations, ctcae~|~nr4a2 gene~|~negation~|~satisfied~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~ask protein, human~|~bcr protein, human~|~hypotension~|~shock~|~specific qualifier value~|~activities scale for kids~|~all~|~anaplastic sarcoma of the kidney~|~bcr gene~|~bcr wt allele~|~dbf4 gene~|~dbf4 wt allele~|~hypotension, ctcae~|~hypothermia (central) (local)~|~hypothermia due to exposure~|~hypothermia, ctcae~|~hypothermia, natural~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules
bad protein~|~classification~|~bad gene~|~bad~|~brachial amyotrophic diplegia~|~nr4a2 gene~|~negation~|~acute onset pain
pain~|~chest pain~|~andorra~|~address type - office~|~and~|~and - dosing instruction fragment~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~office~|~organization unit type - office~|~relationship - father~|~relationshipconjunction - and~|~specific qualifier value~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~entire right shoulder region~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~feel pain~|~frequency of pain question~|~general symptom~|~have pain~|~how much distress pain~|~hypertensive disease~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~structure of right shoulder region~|~usual severity pain
respiratory rate~|~dyspnea~|~disease~|~best1 gene~|~fighting~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~worried~|~best (quality)~|~breaths:number = count/time:point in time:respiratory system:quantitative~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
namenda~|~nausea~|~somnolence~|~bothered by nausea~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~drowsiness~|~drowsiness visual analogue scale~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~not otherwise specified~|~usual severity nausea~|~generalized aches and pains
emend~|~not otherwise specified~|~send (transmission)~|~test categorized by action status
maintenance~|~changed status~|~changing~|~maintenance clinical trial setting~|~not otherwise specified~|~status~|~what subject filter - status~|~change of tube
angina pectoris~|~chest pain~|~satisfaction~|~anxiety~|~chest pain:finding:point in time:^patient:ordinal~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~awareness of heart beat~|~emotionally satisfied with extremity~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~nr4a2 gene~|~negation~|~off~|~relationship - father~|~satisfied~|~specific qualifier value
risk~|~influenza~|~congestive heart failure~|~dyspnea~|~influenza virus vaccine~|~awareness~|~satisfaction~|~influenza virus~|~orthomyxoviridae~|~due to~|~in addition to~|~manifest~|~manifestation of~|~with - dosing instruction fragment~|~hypertensive disease~|~diagnosis~|~container status - identified~|~emotionally satisfied with extremity~|~general surgery specialty~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~hypertension, ctcae~|~identified~|~including (qualifier)~|~level of care - surgery~|~nr4a2 gene~|~negation~|~not otherwise specified~|~operative surgical procedures~|~satisfied~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specimen source codes - respiratory~|~subject risk~|~surgery specialty~|~surgical aspects~|~usual severity shortness of breath~|~without~|~respiratory~|~increase in blood pressure~|~injury wounds~|~reading (activity)~|~reading (datum presentation)~|~reading ability question~|~route of administration - wound~|~specimen source codes - wound~|~specimen type - wound~|~traumatic injury
zetia~|~facial paresis~|~flonase~|~andorra~|~brain~|~oxaliplatin~|~not otherwise specified~|~and~|~and - dosing instruction fragment~|~cerebral hemisphere structure (body structure)~|~ehd1 wt allele~|~injection, oxaliplatin, 0.5 mg administered~|~in the past~|~poor responsiveness~|~relationshipconjunction - and
asbestos~|~alcohol abuse~|~andorra~|~italy~|~alcohol abuse scale (basc-2)~|~alcohol abuse with intoxication, unspecified~|~and~|~and - dosing instruction fragment~|~fighting~|~gauge (physical object)~|~gauges (qualifier value)~|~in addition to~|~relationshipconjunction - and~|~slurred speech~|~uncomplicated~|~with - dosing instruction fragment~|~insertion of pack (procedure)~|~intrathecal route of drug administration~|~packing (action)~|~packing dosage form~|~packing material
histidine~|~mental orientation~|~ask protein, human~|~akr1b10 gene~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~cdisc adas-cog - orientation summary score~|~dbf4 gene~|~dbf4 wt allele~|~genomic orientation~|~histidine measurement~|~montreal cognitive assessment orientation test~|~orientation (spatial)~|~specific qualifier value~|~structure of hippocampal fissure
angina pectoris~|~pelvic pain~|~andorra~|~and~|~and - dosing instruction fragment~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~relationship - father~|~relationshipconjunction - and~|~cardiac pain~|~generalized abdominal pain~|~generalized aches and pains~|~pelvic pain, ctcae 5.0~|~pelvic pain female
satisfaction~|~united arab emirates~|~epileptic syndromes~|~epilepsy~|~foot~|~emotionally satisfied with extremity~|~nr4a2 gene~|~negation~|~satisfied~|~andorra~|~and~|~and - dosing instruction fragment~|~androgen response element~|~empty (qualifier)~|~failure~|~failure (biologic function)~|~feet, unit of measurement~|~free (available (qualifier))~|~free of (attribute)~|~generalized~|~have~|~home environment~|~house (environment)~|~mental status change~|~personal failure~|~relationshipconjunction - and~|~specific qualifier value~|~are unit of measure
colonoscopy~|~syncope~|~satisfaction~|~consent type - colonoscopy~|~emotionally satisfied with extremity~|~hypertension, ctcae~|~hypertensive disease~|~nr4a2 gene~|~negation~|~satisfied~|~unspecified
generalized abdominal pain
atrial fibrillation~|~italy~|~cardiac arrhythmia~|~specific qualifier value~|~disease~|~hospitals~|~intrathecal route of drug administration~|~membrane~|~adverse event associated with cardiac arrhythmia~|~atrial fibrillation by ecg finding~|~atrial fibrillation, ctcae~|~ever told you have or had atrial fibrillation:finding:point in time:^patient:ordinal~|~fibrillation~|~hospital environment~|~membrane device~|~nr4a2 gene~|~negation~|~organization unit type - hospital~|~tissue membrane~|~doubt~|~1/3 meter (distance vision finding)~|~abdominal tenderness~|~abnormally high~|~high~|~high (finding)~|~high level~|~high mitosis-karyorrhexis index~|~ipss risk category high~|~ipss-r risk category high~|~message waiting priority - high~|~near~|~observation value - high~|~unspecified~|~value above reference range~|~high - actexposurelevelcode
narcotics~|~bad protein~|~name~|~fentanyl~|~emend~|~vomiting~|~nr4a2 gene~|~negation~|~bad gene~|~bad~|~brachial amyotrophic diplegia~|~chance~|~entity~|~external cause codes: unspecified~|~fentanyl measurement~|~have~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~post~|~post device~|~slc35g1 gene~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~day~|~bothered by vomiting~|~determined by~|~dioscorea trifida~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~mdf attribute type - name~|~name (property) (qualifier value)~|~name:patient number:point in time:^patient:nominal~|~person name~|~usual severity vomiting~|~vomiting, ctcae
major depressive disorder~|~satisfaction~|~unipolar depression~|~emotionally satisfied with extremity~|~nr4a2 gene~|~negation~|~not otherwise specified~|~satisfied
headache~|~trauma~|~emotional tenderness~|~feeling upset~|~have you felt weak (question)~|~headache, ctcae~|~nr4a2 gene~|~negation~|~not otherwise specified~|~sore to touch~|~trauma, nursing specialty~|~traumatic injury~|~weak~|~weakness~|~wounds and injuries~|~apparently~|~trauma qualifier~|~generalized abdominal pain
unconscious state~|~bread~|~satisfaction~|~not otherwise specified~|~hernia~|~ischemia~|~mental status change~|~emotionally satisfied with extremity~|~ischemia procedure~|~nr4a2 gene~|~negation~|~satisfied~|~sore to touch
chest pain~|~dyspnea~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal~|~lung~|~lung diseases~|~entire lung~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~oral pain
helium~|~mental orientation~|~ask protein, human~|~hyperglycemia~|~satisfaction~|~friend~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~best1 gene~|~cdisc adas-cog - orientation summary score~|~dbf4 gene~|~dbf4 wt allele~|~emotionally satisfied with extremity~|~father (person)~|~father - courtesy title~|~genomic orientation~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~in addition to~|~indirect exposure mechanism - father~|~montreal cognitive assessment orientation test~|~nr4a2 gene~|~negation~|~orientation (spatial)~|~relationship - father~|~relationship - friend~|~satisfied~|~side~|~this (eukaryote)~|~with - dosing instruction fragment~|~best (quality)~|~diabetic~|~cytip gene
clammy skin~|~mental status change~|~not otherwise specified
constipation~|~diarrhea~|~left lower quadrant pain~|~constipation, ctcae~|~diarrhea, ctcae~|~have constipation~|~have diarrhea~|~how much distress constipation~|~how much distress diarrhea~|~how often constipation~|~how often diarrhea~|~usual severity constipation~|~usual severity diarrhea~|~generalized abdominal pain~|~nausea and vomiting
hypotension~|~hypotension, ctcae~|~specific qualifier value
pain~|~not otherwise specified~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
lightheadedness~|~dizziness~|~andorra~|~and~|~and - dosing instruction fragment~|~indication of (contextual qualifier)~|~relationshipconjunction - and~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
muscle cramp~|~spasm~|~craniocerebral trauma~|~constipation~|~andorra~|~bronchospasm~|~and~|~and - dosing instruction fragment~|~bronchospasm, ctcae~|~camp gene~|~facilitated oscillatory release technique~|~injury of elbow~|~kantr gene~|~preposition for~|~relationshipconjunction - and~|~wwox gene~|~wwox wt allele~|~acute pain due to trauma
sepsis~|~diarrhea~|~septicemia~|~diarrhea, ctcae~|~external cause codes: unspecified~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~organism~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity diarrhea~|~fever with chills
sepsis~|~classification~|~communicable diseases~|~constipation~|~sedatives~|~septicemia~|~zetia~|~italy~|~organism~|~else~|~have~|~infectious disease pathway~|~mirror~|~nr4a2 gene~|~negation~|~not otherwise specified~|~patient in hospital~|~rapid~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~intrathecal route of drug administration~|~possible~|~possible diagnosis~|~possibly related to intervention
dyspnea~|~hypotension~|~allergic reaction~|~allergy specialty~|~anaphylactic shock~|~anaphylaxis~|~physical examination~|~hypotension, ctcae~|~unspecified~|~hypersensitivity~|~allergic disposition~|~allergy - charge type reason~|~assessed~|~evaluation procedure~|~external cause codes: unspecified~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~knowledge acquisition using a method of assessment~|~not otherwise specified~|~response to antigens~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~undifferentiated sex~|~unspecified - name type~|~unspecified method of administration~|~unspecified state of consciousness~|~usual severity shortness of breath
back pain~|~left upper quadrant pain~|~nonspecific~|~not otherwise specified~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~generalized abdominal pain~|~nausea and vomiting
angina pectoris~|~pain~|~dyspnea~|~dizziness~|~headache~|~back pain~|~lightheadedness~|~nausea~|~satisfaction~|~hospitals~|~bothered by nausea~|~emotionally satisfied with extremity~|~feel nausea~|~have nausea~|~have shortness of breath question~|~headache, ctcae~|~hospital environment~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~organization unit type - hospital~|~satisfied~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~side~|~usual severity nausea~|~usual severity shortness of breath~|~administration method - pain~|~adverse event associated with pain~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~left~|~left sided~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~table cell horizontal align - left~|~usual severity pain
shock, cardiogenic
bronchitis~|~chest pain~|~constipation~|~heartburn~|~shoulder~|~best1 gene~|~constipation, ctcae~|~entire shoulder region~|~have constipation~|~how much distress constipation~|~how often constipation~|~injury of shoulder and upper arm~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~usual severity constipation~|~best (quality)~|~chest pain:finding:point in time:^patient:ordinal
nausea~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~left lower quadrant pain~|~nausea and vomiting
zetia~|~classification~|~difficulty walking~|~nr4a2 gene~|~negation~|~best1 gene~|~cerebellar stroke syndrome~|~fighting~|~good~|~have~|~microplate well~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~well~|~well marginated nodule~|~best (quality)
range of motion, articular~|~andorra~|~alcohol consumption~|~rest~|~disease~|~and~|~and - dosing instruction fragment~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~less than~|~relationship - father~|~relationshipconjunction - and~|~smaller~|~congenital abnormality~|~agitation~|~agitation, ctcae 3.0~|~agitation, ctcae 5.0~|~mobility ability~|~mobility as a finding~|~qualitative mobility~|~specific qualifier value~|~substance~|~event cycle~|~teratologic~|~active~|~active control~|~active license~|~active state~|~active study~|~active brand of pseudoephedrine-triprolidine~|~concept status - active~|~definitely related to intervention~|~document storage - active~|~document storage status - active~|~editstatus - active~|~entity status - active~|~immunization registry status - active~|~managed participation status - active~|~rest gene~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related~|~role status - active~|~active (hl7 rolelink)~|~site-specific telomere resolvase activity
wheezing~|~disease~|~hemorrhage~|~not otherwise specified~|~membrane~|~approximate~|~hilar~|~interested~|~membrane device~|~tissue membrane~|~intestinal hemorrhage nos~|~lower gastrointestinal hemorrhage~|~wheezing, ctcae
dyspareunia~|~dyspareunia (female)~|~dyspareunia, ctcae~|~painful intercourse female~|~specific qualifier value
hyperglycemia~|~disease~|~hypogonadism~|~schizophrenia~|~adult~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~membrane~|~chest pain on breathing~|~father (person)~|~father - courtesy title~|~in addition to~|~indirect exposure mechanism - father~|~membrane device~|~relationship - father~|~tissue membrane~|~with - dosing instruction fragment~|~diabetic~|~legal adult~|~unspecified
speech~|~pain~|~histidine~|~hyperlipidemia~|~chest pain~|~satisfaction~|~nr4a2 gene~|~negation~|~unspecified~|~akr1b10 gene~|~emotionally satisfied with extremity~|~father (person)~|~father - courtesy title~|~histidine measurement~|~hyperlipidemia, ctcae~|~indirect exposure mechanism - father~|~not otherwise specified~|~relationship - father~|~sostdc1 gene~|~sostdc1 wt allele~|~satisfied~|~serum lipids high (finding)~|~structure of hippocampal fissure~|~undifferentiated sex~|~unspecified method of administration~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
nausea and vomiting
aspirin~|~melatonin~|~dehydration~|~dyspnea~|~sleeplessness~|~hypertrophy~|~best1 gene~|~dehydration procedure~|~dehydration, ctcae~|~dyspnea, ctcae~|~in addition to~|~insomnia, ctcae 3.0~|~insomnia, ctcae 5.0~|~melatonin measurement~|~nonspecific~|~not otherwise specified~|~recombinant melatonin~|~sleep quality question~|~with - dosing instruction fragment~|~best (quality)~|~diabetic~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~relationship - father
cerebral infarction~|~transient ischemic attack~|~gait~|~range of motion, articular~|~andorra~|~congenital abnormality~|~and~|~and - dosing instruction fragment~|~mobility ability~|~mobility as a finding~|~not otherwise specified~|~qualitative mobility~|~relationshipconjunction - and~|~specific qualifier value~|~teratologic~|~possible~|~possible diagnosis~|~possibly related to intervention
tachycardia~|~best1 gene~|~fighting~|~hint1 gene~|~heparin-induced thrombocytopenia~|~hit - database search return~|~nr4a2 gene~|~negation~|~not otherwise specified~|~struck by~|~best (quality)~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
syncope~|~awareness~|~disease~|~vasculitis~|~authorization documentation~|~consent mode - verbal~|~others - allergy~|~participation mode - verbal~|~slurred speech~|~vasculitis, ctcae~|~verbal~|~authorization~|~other medicated shampoos in atc
hot temperature~|~acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~pain~|~hospice care~|~histidine~|~toes~|~fingers~|~chest pain~|~bcr protein, human~|~foot~|~hand~|~andorra~|~chest pain on breathing~|~neck~|~respiration disorders~|~adhfe1 gene~|~akr1b10 gene~|~all~|~and~|~and - dosing instruction fragment~|~bcr gene~|~bcr wt allele~|~entire foot~|~entire hand~|~entire neck~|~feet, unit of measurement~|~fingers, unit of measurement~|~foot british~|~histidine measurement~|~hot sensation quality~|~international foot~|~neck of pancreas~|~neck of urinary bladder~|~relationshipconjunction - and~|~respiratory tract diseases~|~special~|~specialized~|~specific qualifier value~|~structure of hippocampal fissure~|~survey foot~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~dendritic spine neck~|~hand - unit of measure~|~hospice environment~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
dyspnea~|~andorra~|~symptoms~|~and~|~and - dosing instruction fragment~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~best1 gene~|~drowsiness~|~emotional well-being~|~emotional state observations~|~emotional states~|~father (person)~|~father - courtesy title~|~feel drowsy~|~indirect exposure mechanism - father~|~involvement with~|~relationship - father~|~symptoms aspect~|~best (quality)
dyspnea~|~nausea~|~satisfaction~|~chronic obstructive airway disease~|~fatigue~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~bothered by nausea~|~emotionally satisfied with extremity~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~satisfied~|~usual severity nausea~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue
hemorrhage~|~not otherwise specified
chest pain~|~chest pain:finding:point in time:^patient:ordinal
unconscious state~|~hospice care~|~andorra~|~epileptic syndromes~|~foot~|~satisfaction~|~symptoms~|~and~|~and - dosing instruction fragment~|~not otherwise specified~|~relationshipconjunction - and~|~cdisc sdtm size terminology~|~emotionally satisfied with extremity~|~father (person)~|~father - courtesy title~|~feet, unit of measurement~|~generalized~|~indirect exposure mechanism - father~|~nr4a2 gene~|~negation~|~relationship - father~|~satisfied~|~severe infection~|~symptoms aspect~|~this (eukaryote)~|~hospice environment~|~idiopathic epilepsy~|~size~|~size - solid dosage form~|~left cheek~|~unconscious personality factor
gait~|~infarction~|~range of motion, articular~|~hyperglycemia~|~andorra~|~and~|~and - dosing instruction fragment~|~external cause codes: unspecified~|~father (person)~|~father - courtesy title~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~indirect exposure mechanism - father~|~mobility ability~|~mobility as a finding~|~packaging tube~|~qualitative mobility~|~relationship - father~|~relationshipconjunction - and~|~tube1 gene~|~tube (unit of presentation)~|~tube - unit dose~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~biomedical tube device~|~tube
pain~|~andorra~|~hemorrhage~|~and~|~and - dosing instruction fragment~|~cdisc sdtm size terminology~|~father (person)~|~father - courtesy title~|~generalized~|~hypertension, ctcae~|~hypertensive disease~|~indirect exposure mechanism - father~|~relationship - father~|~relationshipconjunction - and~|~specific qualifier value~|~size~|~size - solid dosage form~|~abnormal~|~abnormal reference range~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~general symptom~|~have pain~|~how much distress pain~|~observation interpretation - abnormal~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~unspecified~|~usual severity pain
sneezing~|~personnel selection~|~disease~|~membrane~|~membrane device~|~sneezing, ctcae~|~tissue membrane~|~without
hospice care~|~dyspnea~|~chest pain~|~anxiety~|~anxiety disorders~|~accelerated angina~|~anatomic site~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~site~|~specimen source codes - site~|~study site~|~usual severity shortness of breath~|~hospice environment~|~chest pain:finding:point in time:^patient:ordinal
toes~|~fingers~|~back pain~|~constipation~|~foot~|~hhip protein, human~|~hand~|~rpl29 protein, human~|~st13 protein, human~|~satisfaction~|~andorra~|~and~|~and - dosing instruction fragment~|~bone structure of ischium~|~emotionally satisfied with extremity~|~entire foot~|~feet, unit of measurement~|~fingers, unit of measurement~|~foot british~|~hhip gene~|~hhip wt allele~|~hip structure~|~injury of shoulder and upper arm~|~international foot~|~limb structure~|~nr4a2 gene~|~negation~|~reg3a gene~|~reg3a wt allele~|~rpl29 gene~|~rpl29 wt allele~|~relationshipconjunction - and~|~st13 gene~|~st13 wt allele~|~satisfied~|~specific qualifier value~|~structure of habenulopeduncular tract~|~survey foot~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~yes portal~|~yes1 gene~|~yes1 wt allele~|~yes (indicator)~|~yes - assignment of benefits~|~yes - event expected~|~yes - event seriousness~|~yes - expanded yes/no indicator~|~yes - identity may be divulged~|~yes - notify clergy code~|~yes - presence findings~|~yes - release information~|~yes - yes/no indicator~|~around~|~heme iron polypeptide~|~absence of pain~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~had no pain~|~neck pain score 0~|~no extremity pain
dizziness~|~lightheadedness~|~less than~|~not otherwise specified~|~precision - year~|~transaction counts and value totals - year~|~year~|~nausea and vomiting
sepsis~|~membrane~|~septicemia~|~andorra~|~disease~|~adult~|~membrane device~|~tissue membrane~|~and~|~and - dosing instruction fragment~|~hilar~|~organism~|~relationshipconjunction - and~|~sepsis (invertebrate)~|~sepsis, ctcae~|~adult disease~|~legal adult
pain~|~abdominal pain~|~hhip protein, human~|~rpl29 protein, human~|~st13 protein, human~|~bornholm eye disease~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~beds~|~chest~|~bone structure of ischium~|~hhip gene~|~hhip wt allele~|~hip structure~|~reg3a gene~|~reg3a wt allele~|~rpl29 gene~|~rpl29 wt allele~|~st13 gene~|~st13 wt allele~|~specific qualifier value~|~structure of habenulopeduncular tract~|~heme iron polypeptide~|~bachelor of education~|~ehd1 wt allele~|~entire thorax~|~external cause codes: unspecified~|~in the past~|~patient location - bed~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~1 (finding)~|~abdominal pain, ctcae 5~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~one~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
schizophrenia~|~heart~|~entire heart~|~specific qualifier value